The vision of Cancer Research UK is to conquer cancer through world-class research, aiming to control the disease within two generations. We are the largest volunteer-supported cancer research organisation in the world. With a dedicated team of 4,250 scientists and an annual scientific spend of more than £343 million (2007/08) – raised almost entirely through public donations. > Key Research Areas > Wessex Medical Oncology > Research at The Somers Cancer Research Institute Cancer Research UK will work alone and in partnership with others to achieve the following objectives: 1) To carry out word-class research into the biology and causes of cancer. Cancer is a highly complex disease that is still only partly understood. Only through a better understanding of the disease will the improved treatments, diagnostics and prevention strategies of the future be developed. 2) To develop effective treatments and improve the quality of life for cancer patients - Research will be carried out to accelerate cancer cure rates, aiming to translate our understanding of the disease into effective treatments. Research will also be directed at improving the quality of life of those patients whose disease cannot be cured. 3) To reduce the number of people getting cancer - Research will be carried out into the influence of lifestyle, individual risk, environment and interventions such as vaccination on cancer, and into how people can change their behaviours to reduce their risk of the disease. We will make the wider public aware of cancer risk factors and the options available to them to reduce that risk. 4) To provide alternative information on cancer - As a leading international research organisation, Cancer Research UK will provide authorative cancer information to the public and promote the best treatments and prevention strategies to governments, commercial organisations, those responsible for cancer care and the media.
Read about the research work undertaken at the Southampton Cancer Research UK Centre in their newsletter here.
|
